The probiotics showed the most pronounced effects in restoring anti-inflammatory cytokines (IL-10) and reducing pro-inflammatory markers such as TNF-α and IL-17, highlighting their potential as a therapeutic intervention in PCOS. Here, IL17A is linked to polycystic ovary syndrome.